Product NDC: | 54868-5957 |
Proprietary Name: | TUSSICAPS |
Non Proprietary Name: | hydrocodone polistirex and chlorpheniramine polistirex |
Active Ingredient(s): | 8; 10 mg/1; mg/1 & nbsp; hydrocodone polistirex and chlorpheniramine polistirex |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54868-5957 |
Labeler Name: | Physicians Total Care, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077273 |
Marketing Category: | ANDA |
Start Marketing Date: | 20081027 |
Package NDC: | 54868-5957-0 |
Package Description: | 20 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54868-5957-0) |
NDC Code | 54868-5957-0 |
Proprietary Name | TUSSICAPS |
Package Description | 20 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54868-5957-0) |
Product NDC | 54868-5957 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | hydrocodone polistirex and chlorpheniramine polistirex |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20081027 |
Marketing Category Name | ANDA |
Labeler Name | Physicians Total Care, Inc. |
Substance Name | CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE |
Strength Number | 8; 10 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Opioid Agonist [EPC],Opioid Agonists [MoA],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |